Denise Barnes counsels clients in high-stakes matters related to fraud allegations, including in healthcare, federal contract procurement, and securities and financial services. A former trial attorney with the U.S. Department of Justice (DOJ), she has extensive experience handling issues related to compliance, white-collar and regulatory investigations, and complex commercial litigation. Notably, during her tenure at the DOJ, she spearheaded numerous multi-district investigations that resulted in over $2.7 billion in recoveries for federal taxpayers.
Denise represents businesses in public and non-public investigations, regulatory inquiries, and proceedings involving federal and state agencies. She frequently assists clients navigating government investigations related to allegations arising under the False Claims Act (FCA), Anti-Kickback Statute (AKS), Stark Law, and Financial Institutions Reform, Recovery, and Enforcement Act (FIRREA). She is also a member of the firm’s national Skin Substitutes, Wound Care, and Cellular & Tissue-Based Products (CTP) Task Force, a multidisciplinary team focused on government investigations, enforcement actions and regulatory compliance involving skin substitutes and advanced wound care products.
Denise’s notable accomplishments include investigating and settling high-profile cases involving major financial institutions, hospital systems, and government contractors, displaying a unique skill-set and holistic experience in navigating intricate legal landscapes. She leverages this extensive experience to represent clients in a myriad of investigations and compliance matters.
Denise Barnes counsels clients in high-stakes matters related to fraud allegations, including in healthcare, federal contract procurement, and securities and financial services. A former trial attorney with the U.S. Department of Justice (DOJ), she has extensive experience handling issues related to compliance, white-collar and regulatory investigations, and complex commercial litigation. Notably, during her tenure at the DOJ, she spearheaded numerous multi-district investigations that resulted in over $2.7 billion in recoveries for federal taxpayers.
Denise represents businesses in public and non-public investigations, regulatory inquiries, and proceedings involving federal and state agencies. She frequently assists clients navigating government investigations related to allegations arising under the False Claims Act (FCA), Anti-Kickback Statute (AKS), Stark Law, and Financial Institutions Reform, Recovery, and Enforcement Act (FIRREA). She is also a member of the firm’s national Skin Substitutes, Wound Care, and Cellular & Tissue-Based Products (CTP) Task Force, a multidisciplinary team focused on government investigations, enforcement actions and regulatory compliance involving skin substitutes and advanced wound care products.
Denise’s notable accomplishments include investigating and settling high-profile cases involving major financial institutions, hospital systems, and government contractors, displaying a unique skill-set and holistic experience in navigating intricate legal landscapes. She leverages this extensive experience to represent clients in a myriad of investigations and compliance matters. She provides strategic counsel with a focus on:
- False Claims Act – Defending clients related to FCA investigations by the DOJ and U.S. Attorneys’ Office, as well as internal audits and investigations.
- Anti-Kickback Statute and Stark Law Risk – Providing counsel to ensure compliance and mitigate risk related to AKS and Stark Law.
- FIRREA and Financial Fraud – Defending clients related to financial fraud investigations by the DOJ, U.S. Attorneys’ Office, and the U.S. Securities and Exchange Commission.
- Medicare Reimbursement – Representing hospital systems in Medicare reimbursement appeals before the Provider Reimbursement Review Board.
Denise is also a recognized leader in her practice, frequently participating in various speaking engagements and authoring articles on critical topics such as cybersecurity, government contract billing, financial data rights, and developments related to the FCA. She earned a Special Commendation Award from the U.S. Department of Justice Civil Division in 2019.
